1bm7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1bm7.gif|left|200px]]
[[Image:1bm7.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1bm7 |SIZE=350|CAPTION= <scene name='initialview01'>1bm7</scene>, resolution 2.00&Aring;
+
The line below this paragraph, containing "STRUCTURE_1bm7", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=FLF:2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO]+BENZOIC+ACID'>FLF</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1bm7| PDB=1bm7 | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1bm7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1bm7 OCA], [http://www.ebi.ac.uk/pdbsum/1bm7 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1bm7 RCSB]</span>
+
-
}}
+
'''HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID)'''
'''HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID)'''
Line 28: Line 25:
[[Category: Klabunde, T.]]
[[Category: Klabunde, T.]]
[[Category: Sacchettini, J C.]]
[[Category: Sacchettini, J C.]]
-
[[Category: thyroxine transport]]
+
[[Category: Thyroxine transport]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:41:31 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 19:03:54 2008''
+

Revision as of 08:41, 2 May 2008

Template:STRUCTURE 1bm7

HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID)


Overview

Insoluble protein fibrils resulting from the self-assembly of a conformational intermediate are implicated as the causative agent in several severe human amyloid diseases, including Alzheimer's disease, familial amyloid polyneuropathy, and senile systemic amyloidosis. The latter two diseases are associated with transthyretin (TTR) amyloid fibrils, which appear to form in the acidic partial denaturing environment of the lysosome. Here we demonstrate that flufenamic acid (Flu) inhibits the conformational changes of TTR associated with amyloid fibril formation. The crystal structure of TTR complexed with Flu demonstrates that Flu mediates intersubunit hydrophobic interactions and intersubunit hydrogen bonds that stabilize the normal tetrameric fold of TTR. A small-molecule inhibitor that stabilizes the normal conformation of a protein is desirable as a possible approach to treat amyloid diseases. Molecules such as Flu also provide the means to rigorously test the amyloid hypothesis, i.e., the apparent causative role of amyloid fibrils in amyloid disease.

About this Structure

1BM7 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation., Peterson SA, Klabunde T, Lashuel HA, Purkey H, Sacchettini JC, Kelly JW, Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12956-60. PMID:9789022 Page seeded by OCA on Fri May 2 11:41:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools